Single-Cell Multiomics Analysis for Drug Discovery

Given the heterogeneity seen in cell populations within biological systems, analysis of single cells is necessary for studying mechanisms that cannot be identified on a bulk population level. There are significant variations in the biological and physiological function of cell populations due to the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sam F. Nassar, Khadir Raddassi, Terence Wu
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/49983e110db8453e949658b83450a736
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:49983e110db8453e949658b83450a736
record_format dspace
spelling oai:doaj.org-article:49983e110db8453e949658b83450a7362021-11-25T18:20:30ZSingle-Cell Multiomics Analysis for Drug Discovery10.3390/metabo111107292218-1989https://doaj.org/article/49983e110db8453e949658b83450a7362021-10-01T00:00:00Zhttps://www.mdpi.com/2218-1989/11/11/729https://doaj.org/toc/2218-1989Given the heterogeneity seen in cell populations within biological systems, analysis of single cells is necessary for studying mechanisms that cannot be identified on a bulk population level. There are significant variations in the biological and physiological function of cell populations due to the functional differences within, as well as between, single species as a result of the specific proteome, transcriptome, and metabolome that are unique to each individual cell. Single-cell analysis proves crucial in providing a comprehensive understanding of the biological and physiological properties underlying human health and disease. Omics technologies can help to examine proteins (proteomics), RNA molecules (transcriptomics), and the chemical processes involving metabolites (metabolomics) in cells, in addition to genomes. In this review, we discuss the value of multiomics in drug discovery and the importance of single-cell multiomics measurements. We will provide examples of the benefits of applying single-cell omics technologies in drug discovery and development. Moreover, we intend to show how multiomics offers the opportunity to understand the detailed events which produce or prevent disease, and ways in which the separate omics disciplines complement each other to build a broader, deeper knowledge base.Sam F. NassarKhadir RaddassiTerence WuMDPI AGarticlemultiomicsgenomicsmetabolomicsproteomicstranscriptomicssingle-cellMicrobiologyQR1-502ENMetabolites, Vol 11, Iss 729, p 729 (2021)
institution DOAJ
collection DOAJ
language EN
topic multiomics
genomics
metabolomics
proteomics
transcriptomics
single-cell
Microbiology
QR1-502
spellingShingle multiomics
genomics
metabolomics
proteomics
transcriptomics
single-cell
Microbiology
QR1-502
Sam F. Nassar
Khadir Raddassi
Terence Wu
Single-Cell Multiomics Analysis for Drug Discovery
description Given the heterogeneity seen in cell populations within biological systems, analysis of single cells is necessary for studying mechanisms that cannot be identified on a bulk population level. There are significant variations in the biological and physiological function of cell populations due to the functional differences within, as well as between, single species as a result of the specific proteome, transcriptome, and metabolome that are unique to each individual cell. Single-cell analysis proves crucial in providing a comprehensive understanding of the biological and physiological properties underlying human health and disease. Omics technologies can help to examine proteins (proteomics), RNA molecules (transcriptomics), and the chemical processes involving metabolites (metabolomics) in cells, in addition to genomes. In this review, we discuss the value of multiomics in drug discovery and the importance of single-cell multiomics measurements. We will provide examples of the benefits of applying single-cell omics technologies in drug discovery and development. Moreover, we intend to show how multiomics offers the opportunity to understand the detailed events which produce or prevent disease, and ways in which the separate omics disciplines complement each other to build a broader, deeper knowledge base.
format article
author Sam F. Nassar
Khadir Raddassi
Terence Wu
author_facet Sam F. Nassar
Khadir Raddassi
Terence Wu
author_sort Sam F. Nassar
title Single-Cell Multiomics Analysis for Drug Discovery
title_short Single-Cell Multiomics Analysis for Drug Discovery
title_full Single-Cell Multiomics Analysis for Drug Discovery
title_fullStr Single-Cell Multiomics Analysis for Drug Discovery
title_full_unstemmed Single-Cell Multiomics Analysis for Drug Discovery
title_sort single-cell multiomics analysis for drug discovery
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/49983e110db8453e949658b83450a736
work_keys_str_mv AT samfnassar singlecellmultiomicsanalysisfordrugdiscovery
AT khadirraddassi singlecellmultiomicsanalysisfordrugdiscovery
AT terencewu singlecellmultiomicsanalysisfordrugdiscovery
_version_ 1718411317348401152